Clinical Trials Browser

Phase 1 × OTHER_GOV × Ipilimumab × Clear all

NCT04463368 2025-03-28

SCANDIUM II

Phase 1 Completed

Uveal Melanoma

NCT05088889 2023-11-28

Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer

Phase 1 Unknown

Gastrointestinal

Pancreatic Neoplasms